Zdrowie i gospodarka · 11/06/2010

FDA Releases Guidance on Bioequivalence Recommendations for Specific Products

The Food and Drug Administration (FDA) has made available a new guidance document titled "Bioequivalence Recommendations for Specific Products," which outlines a streamlined process for designing product-specific bioequivalence studies to support abbreviated new drug applications (ANDAs). The FDA aims to facilitate public input and comment on these recommendations through its website.